ConductScience.org, home

Paper39882155

Photodynamic Therapy Mediated by Curcumin and Blue Light for Recurrent Herpes Labialis: A Case Report.

Khalil M and 1 other. Clin Case Rep, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Photodynamic Therapy Mediated by Curcumin and Blue Light for Recurrent Herpes Labialis: A Case Report. Papers, record 39882155. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39882155

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Photodynamic Therapy Mediated by Curcumin and Blue Light for Recurrent Herpes Labialis: A Case Report.
PubMed
Journal
Clin Case Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-01-31
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Khalil MMarwahttps://orcid.org/0000-0002-4100-7853
2Hamadah OOmar

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19700525Photodynamic antimicrobial chemotherapy (PACT).J Antimicrob Chemother1998https://conductscience.org/library/papers/9700525PubMed
233212267Photodynamic therapy and Acyclovir in the treatment of recurrent herpes labialis: A controlled randomized clinical trial.Photodiagnosis Photodyn Ther2021https://conductscience.org/library/papers/33212267PubMed
328681068Photodynamic Therapy with Red Light and 5-Aminolaevulinic Acid for Herpes Simplex Recurrence: Preliminary Results.Acta Derm Venereol2017https://conductscience.org/library/papers/28681068PubMed
431932389
Efficacy of a topical herbal and mineral formulation (Dynamiclear) for the treatment of herpes simplex labialis in the community setting: study protocol for a randomised, double-blind placebo-controlled trial.
BMJ Open2020https://conductscience.org/library/papers/31932389PubMed
532195950Treatment of herpes labialis by photodynamic therapy: Study protocol clinical trial (SPIRIT compliant).Medicine (Baltimore)2020https://conductscience.org/library/papers/32195950PubMed
629378256Curcumin-mediated Photodynamic Therapy for the treatment of oral infections-A review.Photodiagnosis Photodyn Ther2018https://conductscience.org/library/papers/29378256PubMed
737505438Acyclovir-resistant HSV-1 isolates among immunocompromised patients in southern Taiwan: Low prevalence and novel mutations.J Med Virol2023https://conductscience.org/library/papers/37505438PubMed
830274257Photodynamic Inactivation of Herpes Simplex Viruses.Viruses2018https://conductscience.org/library/papers/30274257PubMed
931648056"Efficacy of photodynamic therapy on the treatment of herpes labialis: A systematic review".Photodiagnosis Photodyn Ther2020https://conductscience.org/library/papers/31648056PubMed
1032998270Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma.Int J Mol Sci2020https://conductscience.org/library/papers/32998270PubMed
1118197856Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features.J Oral Pathol Med2008https://conductscience.org/library/papers/18197856PubMed
1225900893Genotoxic effect of photodynamic therapy mediated by curcumin on Candida albicans.FEMS Yeast Res2015https://conductscience.org/library/papers/25900893PubMed
1333894370Effectiveness of photodynamic therapy as an adjunct to topical antiviral therapy in the treatment of herpes labialis: A randomized controlled clinical trial.Photodiagnosis Photodyn Ther2021https://conductscience.org/library/papers/33894370PubMed
1434800566Antimicrobial blue light: A 'Magic Bullet' for the 21st century and beyond?Adv Drug Deliv Rev2022https://conductscience.org/library/papers/34800566PubMed
1511160032The many challenges of facial herpes simplex virus infection.J Antimicrob Chemother2001https://conductscience.org/library/papers/11160032PubMed
1616008638Psychometric properties of the Brazilian version of the Oral Health Impact Profile-short form.Community Dent Oral Epidemiol2005https://conductscience.org/library/papers/16008638PubMed
1733572685Nutraceutical Curcumin with Promising Protection against Herpesvirus Infections and Their Associated Inflammation: Mechanisms and Pathways.Microorganisms2021https://conductscience.org/library/papers/33572685PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
42737488Coumarin and Curcumin-Metal Complexes as Next-Generation Photosensitizers in Cancer Photodynamic Therapy.Int J Mol Sci2026https://conductscience.org/library/papers/42737488

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39882155

GET https://conductscience.org/api/papers/v1/39882155/authors